TACROLIMUS 0.1%- tacrolimus 0.1% solution 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

TACROLIMUS 0.1%

Directions for use

ws

Sincerus Florida, LLC. Adverse reactions

da

Active, inactive

cs

NDC 72934-4173-8. TACROLIMUS MONOHYDRATE USP 0.1%. Solution 60 gm.

zc

TACROLIMUS 0.1% 
tacrolimus 0.1% solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-4173
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TACROLIMUS (UNII: WM0HAQ4WNM) (TACROLIMUS ANHYDROUS - UNII:Y5L2157C4J) TACROLIMUS ANHYDROUS0.1 g  in 100 g
Product Characteristics
Colorwhite (clear solution) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-4173-860 g in 1 BOTTLE, GLASS; Type 0: Not a Combination Product05/10/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/10/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-4173)

Revised: 5/2019
Document Id: 8875fc25-e9f1-4221-e053-2995a90afc97
Set id: 8875fc25-e9f0-4221-e053-2995a90afc97
Version: 1
Effective Time: 20190509
 
Sincerus Florida, LLC